🇫🇷 TRASTUZUMAB DERUXTECAN in France

TRASTUZUMAB DERUXTECAN (TRASTUZUMAB DERUXTECAN) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Enhertu
  • Status: approved

TRASTUZUMAB DERUXTECAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRASTUZUMAB DERUXTECAN approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for TRASTUZUMAB DERUXTECAN in France?

Marketing authorisation holder not available in our data.